Differential effects of MDMA and methylphenidate on social cognition

Journal of Psychopharmacology

Volumn 28, Issue 9, 2014, Pages 847-856

  Schmid, Yasmin ^a   Hysek, Cédric M ^a   Simmler, Linda D ^a   Crockett, Molly J ^b   Quednow, Boris B ^c   Liechti, Matthias E ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University Hospital of Psychiatry Zurich   (Switzerland)

Author keywords

ecstasy; emotion recognition; empathy; MDMA; methylphenidate; social cognition

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; METHYLPHENIDATE; OXYTOCIN; PLACEBO; PROLACTIN; ADRENALIN; CENTRAL STIMULANT AGENT; HYDROCORTISONE; PSYCHEDELIC AGENT;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG ELIMINATION; DRUG HALF LIFE; EMOTIONALITY; EMPATHY; FACIAL EMOTION RECOGNITION TASK; FACIAL EXPRESSION; FEMALE; FEVER; HUMAN; HUMAN EXPERIMENT; LONELINESS; MALE; MAXIMUM PLASMA CONCENTRATION; MORAL JUDGMENT TASK; MORALITY; MOVIE FOR THE ASSESSMENT OF SOCIAL COGNITION; MULTIFACETED EMPATHY TEST; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECOGNITION; SOCIAL BEHAVIOR; SOCIAL COGNITION; SOCIAL VALUE ORIENTATION TEST; TACHYCARDIA; THEORY OF MIND; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUNTEER; YOUNG ADULT; ADOLESCENT; BLOOD; DOSE RESPONSE; DRUG EFFECTS; EMOTION;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EMOTIONS; EMPATHY; EPINEPHRINE; FACIAL EXPRESSION; FEMALE; HALLUCINOGENS; HUMANS; HYDROCORTISONE; JUDGMENT; MALE; METHYLPHENIDATE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXYTOCIN; PROLACTIN; RECOGNITION (PSYCHOLOGY); YOUNG ADULT;

EID: 84906043974     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114542454     Document Type: Article

References (40)

1. Bedi G, Hyman D, de Wit H. Is ecstasy an 'empathogen'? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry. 2010 ; 68: 1134-1140
2. Brunt TM, Koeter MW, Niesink RJ, et al. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology. 2012 ; 220: 751-762
3. Crockett MJ. The neurochemistry of fairness: Clarifying the link between serotonin and prosocial behavior. Ann N Y Acad Sci. 2009 ; 1167: 76-86
4. Crockett MJ, Clark L, Hauser MD, et al. Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci U S A. 2010 ; 107: 17433-17438
5. Di Simplicio M, Massey-Chase R, Cowen PJ, et al. Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharmacol. 2009 ; 23: 241-248
6. Dumont GJ, Sweep FC, van der Steen R, et al. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci. 2009 ; 4: 359-366
7. Dunand M, Gubian D, Stauffer M, et al. High throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate. Anal Chem. 2013 ; 85: 3539-3544
8. Dziobek I, Fleck S, Kalbe E, et al. Introducing MASC: A movie for the assessment of social cognition. J Autism Dev Disord. 2006 ; 36: 623-636
9. Dziobek I, Rogers K, Fleck S, et al. Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). J Autism Dev Disord. 2008 ; 38: 464-473
10. EMCDDA (2014) European Monitoring Center for Drugs and Drug Addiction (EMCDDA). Available at: www.emcdda.europa.eu/publications/mdma/publications/mdma (accessed 26 June 2014).
11. Harmer CJ, Shelley NC, Cowen PJ, et al. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry. 2004 ; 161: 1256-1263
12. Hurlemann R, Patin A, Onur OA, et al. Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci. 2010 ; 30: 4999-5007
13. Hysek CM, Liechti ME. Effects of MDMA alone and after pretreatement with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology. 2012 ; 224: 363-376
14. Hysek CM, Domes G, Liechti ME. MDMA enhances 'mind reading' of positive emotions and impairs 'mind reading' of negative emotions. Psychopharmacology. 2012a ; 222: 293-302
15. Hysek CM, Schmid Y, Simmler LD, et al. MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci. 2013 ;:
16. Hysek CM, Simmler LD, Ineichen M, et al. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ('ecstasy') in humans. Clin Pharmacol Ther. 2011 ; 90: 246-255
17. Hysek CM, Simmler LD, Nicola V, et al. Duloxetine inhibits effects of MDMA ('ecstasy') in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One. 2012b ; 7: e36476
18. Hysek CM, Simmler LD, Schillinger N, et al. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone and in combination. Int J Neuropsychopharmacol. 2014 ; 17: 371-381
19. Janke W, Debus G Die Eigenschaftswörterliste. Göttingen: Hogrefe ; 1978 :
20. Kamboj SK, Joye A, Bisby JA, et al. Processing of facial affect in social drinkers: A dose-response study of alcohol using dynamic emotion expressions. Psychopharmacology. 2013 ; 227: 31-39
21. Kometer M, Schmidt A, Bachmann R, et al. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biol Psychiatry. 2012 ; 72: 898-906
22. McCabe SE, Knight JR, Teter CJ, et al. Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction. 2005 ; 100: 96-106
23. Maoz H, Tsviban L, Gvirts HZ, et al. Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder. J Psychopharmacol. 2014 ; 28: 212-219
24. Mitchell IJ, Beck SR, Boyal A, et al. Theory of mind deficits following acute alcohol intoxication. Eur Addict Res. 2011 ; 17: 164-168
25. Mithoefer MC, Wagner MT, Mithoefer AT, et al. The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol. 2010 ; 25: 439-452
26. Moore AB, Clark BA, Kane MJ. Who shalt not kill? Individual differences in working memory capacity, executive control, and moral judgment. Psychol Sci. 2008 ; 19: 549-557
27. Morgan CJ, Noronha LA, Muetzelfeldt M, et al. Harms and benefits associated with psychoactive drugs: Findings of an international survey of active drug users. J Psychopharmacol. 2013 ; 27: 497-506
28. Murphy RO, Ackermann KA, Handgraaf MJJ. Measuring social value orientation. Judg Decis Making. 2011 ; 6: 771-781
29. Neumann ID, Maloumby R, Beiderbeck DI, et al. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology. 2013 ; 38: 1985-1993
30. Oehen P, Traber R, Widmer V, et al. A randomized, controlled pilot study of MDMA ±3,4-methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). J Psychopharmacol. 2013 ; 27: 40-52
31. Preller KH, Hulka LM, Vonmoos M, et al. Impaired emotional empathy and related social network deficits in cocaine users. Addict Biol. 2014 ; 19: 452-66
32. Ramos L, Hicks C, Kevin R, et al. Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4- methylenedioxymethamphetamine in rats: Involvement of the V1A receptor. Neuropsychopharmacology. 2013 ; 38: 2249-2259
33. Schmeichel BE, Berridge CW. Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants. Neuropsychopharmacology. 2013 ; 38: 1079-1084
34. Simmler LD, Hysek CM, Liechti ME. Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocrinol Metab. 2011 ; 96: 2844-2850
35. Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One. 2010 ; 5: e12412
36. Thompson MR, Callaghan PD, Hunt GE, et al. A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ('ecstasy'). Neuroscience. 2007 ; 146: 509-514
37. Wardle MC, Garner MJ, Munafo MR, et al. Amphetamine as a social drug: Effects of d-amphetamine on social processing and behavior. Psychopharmacology. 2012 ; 223: 199-210
38. White TL, Justice AJ, de Wit H. Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav. 2002 ; 73: 729-741
39. Williams LM, Hermens DF, Palmer D, et al. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: Evidence for a neural marker and stimulant effects. Biol Psychiatry. 2008 ; 63: 917-926
40. Zerssen DV Die Beschwerden-Liste. Münchener Informationssystem. Munich: Psychis ; 1976 :